"cancer clinical" trang 13 - tải miễn phí từ tailieunhanh
A phase Ia/Ib clinical trial of metronomic chemotherapy based on a mathematical model of oral vinorelbine in metastatic nonsmall cell lung cancer and malignant pleural mesothelioma: Rationale and study protocol

A phase Ia/Ib clinical trial of metronomic chemotherapy based on a mathematical model of oral vinorelbine in metastatic nonsmall cell lung cancer and malignant pleural mesothelioma: Rationale and study protocol
8    51    1
Lgr5 expression is a valuable prognostic factor for colorectal cancer: Evidence from a meta-analysis

Lgr5 expression is a valuable prognostic factor for colorectal cancer: Evidence from a meta-analysis
9    53    1
Prognostic and clinical impact of PIK3CA mutation in gastric cancer: Pyrosequencing technology and literature review

Prognostic and clinical impact of PIK3CA mutation in gastric cancer: Pyrosequencing technology and literature review
8    32    1
Multiple primary malignancies involving lung cancer

Multiple primary malignancies involving lung cancer
8    42    1
Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: Results of a single-center retrospective study

Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: Results of a single-center retrospective study
11    60    1
Does anti-p53 antibody status predict for clinical outcomes in metastatic colorectal cancer patients treated with fluoropyrimidine, oxaliplatin, plus bevacizumab as first-line chemotherapy?

Does anti-p53 antibody status predict for clinical outcomes in metastatic colorectal cancer patients treated with fluoropyrimidine, oxaliplatin, plus bevacizumab as first-line chemotherapy?
9    41    1
Difficulty of predicting the presence of lymph node metastases in patients with clinical early stage gastric cancer: A case control study

Difficulty of predicting the presence of lymph node metastases in patients with clinical early stage gastric cancer: A case control study
9    67    1
Outcomes of prior cervical cytology and HRHPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: A 4-year routine clinical experience after implementation of systematic training and quality control programs

Outcomes of prior cervical cytology and HRHPV testing in women subsequently diagnosed with CIN1, CIN2/3, and invasive cervical cancer: A 4-year routine clinical experience after implementation of systematic training and quality control programs
10    78    1
Organ Preservation in Rectal Adenocarcinoma: A phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management

Organ Preservation in Rectal Adenocarcinoma: A phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management
13    86    1
The effect of pre-diagnostic vitamin D supplementation on cancer survival in women: A cohort study within the UK Clinical Practice Research Datalink

The effect of pre-diagnostic vitamin D supplementation on cancer survival in women: A cohort study within the UK Clinical Practice Research Datalink
7    49    1
Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy

Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy
11    59    1
Research on clinical and paraclinical characteristics of lower third gastric cancer in the elderly at Military hospital 103

Research on clinical and paraclinical characteristics of lower third gastric cancer in the elderly at Military hospital 103
6    52    1
Breast cancer survivors’ recollection of their illness and therapy seven years after enrolment into a randomised controlled clinical trial

Breast cancer survivors’ recollection of their illness and therapy seven years after enrolment into a randomised controlled clinical trial
13    51    1
Tumour biology, metastatic sites and taxanes sensitivity as determinants of eribulin mesylate efficacy in breast cancer: Results from the ERIBEX retrospective, international, multicenter study

Tumour biology, metastatic sites and taxanes sensitivity as determinants of eribulin mesylate efficacy in breast cancer: Results from the ERIBEX retrospective, international, multicenter study
9    46    1
STRATEGIC-1: A multiple-lines, randomized, open-label GERCOR phase III study in patients with unresectable wild-type RAS metastatic colorectal cancer

STRATEGIC-1: A multiple-lines, randomized, open-label GERCOR phase III study in patients with unresectable wild-type RAS metastatic colorectal cancer
13    39    1
Tumour shrinkage at 6 weeks predicts favorable clinical outcomes in a phase III study of gemcitabine and oxaliplatin with or without erlotinib for advanced biliary tract cancer

Tumour shrinkage at 6 weeks predicts favorable clinical outcomes in a phase III study of gemcitabine and oxaliplatin with or without erlotinib for advanced biliary tract cancer
8    50    1
Polymorphisms and plasma levels of IL-27: Impact on genetic susceptibility and clinical outcome of bladder cancer

Polymorphisms and plasma levels of IL-27: Impact on genetic susceptibility and clinical outcome of bladder cancer
10    50    1
The emerging outcome of postoperative radiotherapy for stage IIIA(N2) non-small cell lung cancer patients: Based on the three-dimensional conformal radiotherapy technique and institutional standard clinical target volume

The emerging outcome of postoperative radiotherapy for stage IIIA(N2) non-small cell lung cancer patients: Based on the three-dimensional conformal radiotherapy technique and institutional standard clinical target volume
10    43    1
Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer

Variable expression levels of keratin and vimentin reveal differential EMT status of circulating tumor cells and correlation with clinical characteristics and outcome of patients with metastatic breast cancer
10    32    1
Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer

Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer
11    49    1